Vycor Medical Stock Price Prediction
| VYCO Stock | USD 0.07 0 1.45% |
Oversold Vs Overbought
45
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Vycor Medical based on different types of headlines from major news networks to social media. Using Vycor Medical hype-based prediction, you can estimate the value of Vycor Medical from the perspective of Vycor Medical response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Vycor Medical. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Vycor Medical to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Vycor because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vycor Medical after-hype prediction price | USD 0.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vycor |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vycor Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vycor Medical After-Hype Price Prediction Density Analysis
As far as predicting the price of Vycor Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vycor Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Vycor Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vycor Medical Estimiated After-Hype Price Volatility
In the context of predicting Vycor Medical's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vycor Medical's historical news coverage. Vycor Medical's after-hype downside and upside margins for the prediction period are 0.00 and 12.07, respectively. We have considered Vycor Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vycor Medical is out of control at this time. Analysis and calculation of next after-hype price of Vycor Medical is based on 3 months time horizon.
Vycor Medical OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Vycor Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vycor Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vycor Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.58 | 12.00 | 0.00 | 0.15 | 0 Events / Month | 4 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.07 | 0.07 | 0.00 |
|
Vycor Medical Hype Timeline
Vycor Medical is at this time traded for 0.07. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.15. Vycor is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.58%. %. The volatility of related hype on Vycor Medical is about 4533.09%, with the expected price after the next announcement by competition of 0.22. About 65.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.02. Vycor Medical had not issued any dividends in recent years. The entity had 1:150 split on the 15th of January 2013. Given the investment horizon of 90 days the next forecasted press release will be any time. Check out Vycor Medical Basic Forecasting Models to cross-verify your projections.Vycor Medical Related Hype Analysis
Having access to credible news sources related to Vycor Medical's direct competition is more important than ever and may enhance your ability to predict Vycor Medical's future price movements. Getting to know how Vycor Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vycor Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NPCE | Neuropace | 0.07 | 10 per month | 3.04 | 0.15 | 9.73 | (6.20) | 35.79 | |
| DCTH | Delcath Systems | 1.09 | 7 per month | 3.21 | 0.13 | 6.49 | (4.74) | 20.21 | |
| SRDX | SurModics | 0.13 | 5 per month | 0.47 | (0.01) | 1.06 | (0.93) | 3.22 | |
| OSA | ProSomnus, Common Stock | 0 | 1 per month | 13.81 | 0.13 | 51.22 | (20.31) | 168.97 | |
| CVRX | CVRx Inc | 0.03 | 9 per month | 3.77 | 0.12 | 9.25 | (8.95) | 41.08 |
Vycor Medical Additional Predictive Modules
Most predictive techniques to examine Vycor price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vycor using various technical indicators. When you analyze Vycor charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vycor Medical Predictive Indicators
The successful prediction of Vycor Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vycor Medical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vycor Medical based on analysis of Vycor Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vycor Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vycor Medical's related companies.
Story Coverage note for Vycor Medical
The number of cover stories for Vycor Medical depends on current market conditions and Vycor Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vycor Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vycor Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Vycor Medical Short Properties
Vycor Medical's future price predictability will typically decrease when Vycor Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vycor Medical often depends not only on the future outlook of the potential Vycor Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vycor Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.8 M | |
| Short Long Term Debt | 640.2 K | |
| Shares Float | 12.1 M |
Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.